Our desensitization program prepares even the most highly sensitized patients for transplant. Experienced staff work with the transplant center to develop targeted desensitization protocols decreasing antibodies and minimizing rejection.
Our primary objective is to facilitate successful transplantation.
Transplant Nurse Liaisons initiate patient contact and consent while working with the transplant center to assist in individualized protocol development.
We’ll coordinate tailored outcomes reports, arrange for PRA samples to be sent to HLA labs, establish monthly meetings with the transplant center team, and provide overall medical and administrative management.
A highly qualified infusion nurse administers the desensitization treatment prior to dialysis, minimizing side effects and adverse reactions due to fluid volume. BioMatrix uses a targeted approach by pre-screening patients MFI’s / DSA’s with the HLA laboratory. This significantly increases favorable patient outcomes.
Our model of care produces positive outcomes while reducing overall healthcare expenditures for transplant patients.
BioMatrix assists in reducing hospital stays by developing protocols with the medical team whereby once a patient is admitted for acute/chronic AMR, they can be quickly discharged and treated at home in an outpatient setting. Our proprietary digital health technology minimizes days on dialysis by helping patients receive a transplant sooner, improving quality of life and reducing overall healthcare costs.
BioMatrix is committed to furthering clinical advancements in transplant.
Please click the links below to download our whitepapers on clinical desensitization for kidney and lung transplant recipients.